Virologic and immunologic aspects of HIV–hepatitis C virus coinfection
Antibody responses to prime–boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140
CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection
Reproducing SIVΔnef vaccine correlates of protection
Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy
Enhancement of viral escape in HIV-1 Nef by STEP vaccination
Efavirenz is associated with higher bone mass in South African children with HIV
Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals
Associations between antiretroviral use and subclinical coronary atherosclerosis
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients
Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission
The cardiovascular risk management for people living with HIV in Europe
Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection
Chronic health conditions in Medicare beneficiaries 65 years and older with HIV infection
Acute HIV infection transmission among people who inject drugs in a mature epidemic setting
Life expectancy trends in adults on antiretroviral treatment in South Africa
Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates
The counter effects of the Ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa
Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers
First report of transmission of a highly resistant strain of HIV-1 group O
Children and alternative service delivery models